Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
10/2008
10/08/2008EP1492527B1 Process for preparing a finely self-emulsifiable pharmaceutical composition
10/08/2008EP1487469B1 Co-beadlet of dha and rosemary
10/08/2008EP1476489B8 Hydrolytically degradable alkylene oxide based polymers
10/08/2008EP1471943B1 Conjugate for treating prokaryotic infections
10/08/2008EP1468036B1 Biodegradable polyketal polymers and methods for their formation and use
10/08/2008EP1455761B1 Pharmaceutical compositions for the oral administration of heparin or derivatives thereof
10/08/2008EP1455600B1 Food or pet food composition containing plant extract from amelanchier for bone health
10/08/2008EP1370298B1 Elongated and multiple spacers in activatible prodrugs
10/08/2008EP1357811B1 Composition and method for smoke detoxification
10/08/2008EP1351720B1 Hydrocolloid compositions
10/08/2008EP1333818B1 Titratable dosage transdermal delivery system
10/08/2008EP1320589B1 Antiangiogenic polypeptides and methods for inhibiting angiogenesis
10/08/2008EP1283042B1 Aqueous liquid preparation of pranoprofen
10/08/2008EP1274398B1 Methods for thepreparation of effervescent granules
10/08/2008EP1253918B1 Compositions comprising modafinil for the treatment of attention deficit hyperactivity disorder
10/08/2008EP1141334B1 Human glycosylphosphatidylinositol specific phospholipase d variants and uses thereof
10/08/2008EP1137762B1 Treatment of pompe's disease
10/08/2008EP1044015B1 Formulations for amylin agonist peptides with insulin
10/08/2008EP0902664B1 Synchronising of animal oestrus and intra vaginal devices useful therein
10/08/2008EP0752005B1 Compacted nucleic acids and their delivery to cells
10/08/2008CN101283279A Screening and therapeutic method for nsclc targeting CDCA1-KNTC2 complex
10/08/2008CN101283008A N-vinylcaprolactam-based copolymers and the use thereof as solubilizers
10/08/2008CN101282717A Bitterness-reducing agent
10/08/2008CN101282713A Reduction of saltiness with sweeteners
10/08/2008CN101281810A Surface finished magnetic nano crystal dry powder with activated oxatyl and preparation method thereof
10/08/2008CN101280318A Recombinant human HNP gene liposome complex, preparation and use thereof
10/08/2008CN101280317A FAK and EGFR targeted RNA interference plasmid-lipidosome antineoplastic complex
10/08/2008CN101279096A Pullulan polysaccharide Vc coating combination
10/08/2008CN101279095A Dried composition
10/08/2008CN101279093A Cancer modulation antibody
10/08/2008CN101279091A Pancreatic enzymes enteric coated pellets and preparation
10/08/2008CN101279067A Preparation of shaolin plaster for rheumatism and wound and quality control method
10/08/2008CN101279062A Juhong Tanke dropping pill and method of preparing the same
10/08/2008CN101279022A Preparation of Simotang enema and suppositorium
10/08/2008CN101279008A Chinese medicine pad pasting for preventing and controlling myopic eye, eyestrain symptoms and eyebase ischemia
10/08/2008CN101279003A Enema medicament for promoting anal exsufflation and preparation
10/08/2008CN101279001A Pummelo peel extract and preparation method and application thereof
10/08/2008CN101278977A Method for extracting main active components of mulberry leaf and application of its extract
10/08/2008CN101278965A Soft capsule of humifuse spurge and preparing method thereof
10/08/2008CN101278953A Externally-applied medicine for curing hydrarthrosis of knee and method of processing the same
10/08/2008CN101278948A Biological medical membrane and method of preparing the same
10/08/2008CN101278945A Pearl vitamin E soft capsule
10/08/2008CN101278937A Clear eye lotion containing latanoprost as effective ingredient
10/08/2008CN101278936A Clear eye lotion containing latanoprost as effective ingredient
10/08/2008CN101278934A Oral soft capsule compound preparations for curing cold
10/08/2008CN101278932A Sustained release medicinal compositions containing Zaltoprofen, preparation method and application thereof
10/08/2008CN101278924A Meclofenoxate hydrochloride microcapsule and method for preparing injection thereof
10/08/2008CN101278923A Medicament microcapsule and method for preparing injection thereof
10/08/2008CN101278922A Medicament composition capsule and method of preparing the same
10/08/2008CN101278921A Triopisetron Hydrochloride microcapsule and method for preparing injection
10/08/2008CN101278915A Medicament composition granule and method of preparing the same
10/08/2008CN101278912A Tetrandrine nanoemulsion injection and method of preparing the same
10/08/2008CN101278911A Sustained-release injection containing antibiotic sarafloxacin and uses thereof
10/08/2008CN101278910A Sustained-release injection containing antibiotic doxycycline and uses thereof
10/08/2008CN101278909A Sustained-release injection containing antibiotic danofloxain and uses thereof
10/08/2008CN101278908A Eye drop capable of significantly increasing medicament effect
10/08/2008CN101278907A Coenzyme Q10 injection
10/08/2008CN101278906A Stable lornoxicam solution agent, preparation method and application thereof
10/08/2008CN101278904A Sustained-release injection containing biopalina
10/08/2008CN101278903A Sustained-release injection containing amikacin
10/08/2008CN101278902A Sustained-release injection containing astromicin
10/08/2008CN101278901A Sustained-release injection containing arbekacin
10/08/2008CN101278900A Sustained-release injection containing dibekacin
10/08/2008CN101278899A Sustained-release injection containing kanamycin
10/08/2008CN101278898A Sustained-release injection containing aminoside antibiotics and uses thereof
10/08/2008CN101278896A Chitosan nano silver gel agent and uses thereof
10/08/2008CN101278895A Instant type gel preparation for eye and method of producing the same
10/08/2008CN100424104C Polymer sustainedly releasing amino acid derivative, cosmetic and fiber construct containing the polymer, method of producing the same and method of regenerating the same
10/08/2008CN100423784C Pressure-sensitive adhesive sheet for application to skin
10/08/2008CN100423780C Injectable pharmaceutical slow-release carrier and preparation method thereof
10/08/2008CN100423778C Folic acid receptor targeted liposome medicine carrier, its preparation and application
10/08/2008CN100423774C Process for preparing polysaccharide-protein conjugate vaccines
10/08/2008CN100423730C Medium and method for preserving platelets, red blood cells, and other non-nucleus cells and platelets-containing composition
10/08/2008CN100423726C No dump-agglomeration powder phospholipid and preparation process thereof
10/08/2008CN100423724C Medicine for treating endometriosis and its prepn
10/08/2008CN100423717C Pharmaceutical solutions of modafinil compounds and use in preparation of medicine for treatment of diseases
10/08/2008CN100423716C Modafinil pharmaceutical compositions
10/08/2008CN100423711C Sodium sulfonate injection of tanshinone óA, and preparation method
10/08/2008CN100423710C Medicine composition for treating virus cold and preparing process
10/08/2008CN100423703C Plant candle for ear and its prepn
10/07/2008US7432389 Inhibiting beta-secretase enzyme activity and A beta peptide production, to reduce amyloid beta deposits or plaques
10/07/2008US7432360 Containing 0.001 to 0.01% w/v benzethonium chloride and 0.01 to 0.5% w/v phenoxyethanol or 0.01 to 0.5% w/v phenylethyl alcohol as preservatives; vials for parenteral administration
10/07/2008US7432331 Conjugates formed from the attachment of a maleimide-terminated water soluble polymer reagent to another substance, such as an active agent or surface, drugs/polymer conjugates
10/07/2008US7432330 polymers comprise particular linkers interposed between a polymer segment and a maleimide group
10/07/2008US7432273 cancer and/or viral infection, leukemia; improved pharmacological properties; oral bioavailability, greater potency, extended half-life in vivo, Side effects reduction; 2-{4-[(2,4-Diamino-pteridin-6-ylmethyl)-methyl-amino]-benzoylamino}-6-diethoxy-phosphoryl)-hexanoic acid, diethyl cyano phosphonate
10/07/2008US7432245 Pharmaceutical formulation comprising a peptide angiogenesis inhibitor
10/07/2008US7431943 Controlled release and taste masking oral pharmaceutical compositions
10/07/2008US7431942 Orally disintegrable tablets
10/07/2008US7431939 Inhibition of systemic infections in humans and vertebrates by dietary fibers
10/07/2008US7431921 Interferon beta-like molecules
10/07/2008US7431916 Simultaneous inhalation delivery of at least two drugs with high efficiency to targeted airways and/or lungs
10/07/2008US7431915 Peptides whose uptake by cells is controllable
10/07/2008CA2444071C Oxypurine nucleosides and their congeners, and acyl derivatives thereof, for improvement of hematopoiesis
10/07/2008CA2419147C Fill liquid composition for ibuprofen capsule and capsule preparation
10/07/2008CA2366841C Tolperisone-containing pharmaceutical preparation for oral administration
10/07/2008CA2359872C Gels formed by the interaction of poly(aldehyde) with various substances
10/07/2008CA2350815C Stable amorphous amifostine compositions and methods for the preparation and use of same
10/07/2008CA2338646C Microparticles with adsorbent surfaces, methods of making same, and uses thereof
10/07/2008CA2337855C Redispersible powder and its aqueous dispersion, preparation process and use
10/07/2008CA2321523C Formulation of fast-dissolving efavirenz capsules or tablets using super-disintegrants
1 ... 634 635 636 637 638 639 640 641 642 643 644 645 646 647 648 649 650 651 652 653 654 ... 1712